Stable Isotope Labelled Bamlanivimab Biosimilar – Anti-Covid Spike RBD mAb – Research Grade

Reference: PX-TA1031-SIL-1MG
Size

Brand

Product type

Clonality

Expression system

Applications

Product nameStable Isotope Labelled Bamlanivimab Biosimilar - Anti-Covid Spike RBD mAb - Research Grade
SpeciesHumanized
Expression systemMammalian cells
Molecular weight150kDa
Purity>95%
BufferPBS pH7.5
Delivery conditionBlue Ice
Delivery Time3-5 days if in stock; 5-8 weeks if production needed
Storage condition4°C for short term; -20°C for long term
BrandProteoGenix
ApplicationsMS
Aliases /SynonymsBamlanivimab
ReferencePX-TA1031-SIL
Related ProductsPX-COV-P046
NoteFor research use only. Not suitable for clinical or therapeutic use.
IsotypeIgG1
ClonalityMonoclonal Antibody
FormatLyophilized
LabellingArginine: 13C6,15N4 ; Lysine: 13C6,15N2, >99%
Isotopic Enrichment99%
Stability1 year

Description of Bamlanivimab Biosimilar - Anti-Covid Spike RBD mAb - Research Grade

General information on Anti-SARS-CoV2 Spike RBD (Bamlanivimab) Monoclonal Antibody

Bamlanivimab is a synthetic monoclonal antibody (mAb) that was developped from the first blood samples from COVID-19 recovered patients in the United States. Bamlanivimab is a neutralizing IgG1? mAb targetting the SARS-CoV-2 spike, which prevents the virus from entering human cells. It has been found to recognize first type and variants referenced as PX-COV-P046 and PX-COV-P052.

Reviews

There are no reviews yet.

REVIEW YOUR PRODUCT

Be the first to review “Stable Isotope Labelled Bamlanivimab Biosimilar – Anti-Covid Spike RBD mAb – Research Grade”

Your email address will not be published. Required fields are marked *

Contact us

Send us a message from the form below







    Cart (0 Items)

    Your cart is currently empty.

    View Products